Gadolinium activates and sensitizes the vanilloid receptor TRPV1 through the external protonation sites

被引:47
|
作者
Tousova, K [1 ]
Vyklicky, L [1 ]
Susankova, K [1 ]
Benedikt, J [1 ]
Vlachova, V [1 ]
机构
[1] Acad Sci Czech Republ, Inst Physiol, Dept Cellular Neurophysiol, Prague 14220 4, Czech Republic
关键词
D O I
10.1016/j.mcn.2005.07.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Gadolinium is a recognized blocker of many types of cation channels, including several channels of the transient receptor potential (TRP) superfamilly. In this study, we demonstrate that Gd3+, in addition to its blocking effects, activates and potentiates the recombinant vanilloid receptor TRPV1 expressed in HEK293T cells. Whole-cell, currents through TRPV1 were induced by Gd3+ with a half-maximal activation achieved at 72 mu M at +40 mV. Gd3+, at concentrations up to 100 mu M, lowered the threshold for heat activation and potentiated the currents induced by capsaicin (I [M) and low extracellular pH (6). Higher concentrations of Gd3+ (>300 mu M) blocked the TRPV1 channel. Neutralizations of the two acidic residues, Glu600 and Glu648, which are the key residues conferring the proton-sensitivity to TRPV1, resulted in a loss of Gd3+-induced activation and/or a reduction in its potentiating effects. A trivalent nonlanthanide, Al3+, that possesses much a smaller atomic mass than Gd3+ blocked but did not activate or sensitize the TRPV1 channel. These findings indicate that Gd3+ activates and potentiates the TRPVI by neutralizing two specific proton-sensitive sites on the extracellular side of the pore-forming loop. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:207 / 217
页数:11
相关论文
共 50 条
  • [41] Molecular determinants of vanilloid sensitivity in TRPV1
    Gavva, NR
    Klionsky, L
    Qu, YS
    Shi, LC
    Tamir, R
    Edenson, S
    Zhang, TJ
    Viswanadhan, VN
    Toth, A
    Pearce, LV
    Vanderah, TW
    Porreca, F
    Blumberg, PM
    Lile, J
    Sun, Y
    Wildt, K
    Louis, JC
    Treanor, JJS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) : 20283 - 20295
  • [42] Signalling at vanilloid TRPV1 channels - Introduction
    Di Marzo, V
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (10): : 1813 - 1813
  • [43] Capsaicin, The Vanilloid Receptor TRPV1 Agonist in Neuroprotection: Mechanisms Involved and Significance
    Omar M.E. Abdel-Salam
    Gyula Mózsik
    Neurochemical Research, 2023, 48 : 3296 - 3315
  • [44] TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications
    Avelino, Antonio
    Cruz, Francisco
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 373 (04) : 287 - 299
  • [45] Deletion of vanilloid receptor (TRPV1) in mice alters behavioral effects of ethanol
    Blednov, Y. A.
    Harris, R. A.
    NEUROPHARMACOLOGY, 2009, 56 (04) : 814 - 820
  • [46] TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications
    António Avelino
    Francisco Cruz
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2006, 373 : 287 - 299
  • [47] Structure-activity relationships of vanilloid receptor agonists for arteriolar TRPV1
    Czikora, A.
    Lizanecz, E.
    Bako, P.
    Rutkai, I.
    Ruzsnavszky, F.
    Magyar, J.
    Porszasz, R.
    Kark, T.
    Facsko, A.
    Papp, Z.
    Edes, I.
    Toth, A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (06) : 1801 - 1812
  • [48] Expression of the vanilloid receptor (TRPV1) in bronchi from patients with chronic cough
    Mitchell, JE
    Campbell, AP
    Kastelik, JA
    Mulrennan, SA
    Morice, AH
    THORAX, 2004, 59 (01) : 45 - 45
  • [49] Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists
    Appendino, G
    Harrison, S
    De Petrocellis, L
    Daddario, N
    Bianchi, F
    Moriello, AS
    Trevisani, M
    Benvenuti, F
    Geppetti, P
    Di Marzo, V
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (08) : 1417 - 1424
  • [50] IS TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 (TRPV1) A NEW TARGET FOR CARDIOPROTECTION?
    AL-Mawla, R.
    Paita, L.
    Bidault-Ducreux, S.
    Chouabe, C.
    Durand, A.
    Augeul, L.
    Dupre-Aucouturier, S.
    Bonvallet, R.
    Ovize, M.
    Van Coppenolle, F.
    JOURNAL OF HYPERTENSION, 2016, 34 : E212 - E213